Geode Capital Management’s MiNK Therapeutics INKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86K | Buy |
11,492
+238
| +2% | +$1.78K | ﹤0.01% | 4102 |
|
|
2025
Q1 | $97.3K | Sell |
11,254
-84,859
| -88% | -$733K | ﹤0.01% | 4039 |
|
|
2024
Q4 | $67K | Sell |
96,113
-1,868
| -2% | -$1.3K | ﹤0.01% | 4190 |
|
|
2024
Q3 | $73.5K | Buy |
97,981
+1,634
| +2% | +$1.23K | ﹤0.01% | 4178 |
|
|
2024
Q2 | $91.5K | Buy |
96,347
+7,491
| +8% | +$7.11K | ﹤0.01% | 4161 |
|
|
2024
Q1 | $80.7K | Sell |
88,856
-1,308
| -1% | -$1.19K | ﹤0.01% | 4226 |
|
|
2023
Q4 | $96.9K | Hold |
90,164
| – | – | ﹤0.01% | 4196 |
|
|
2023
Q3 | $106K | Sell |
90,164
-2,559
| -3% | -$3K | ﹤0.01% | 4231 |
|
|
2023
Q2 | $195K | Buy |
92,723
+67,428
| +267% | +$142K | ﹤0.01% | 4057 |
|
|
2023
Q1 | $48.6K | Hold |
25,295
| – | – | ﹤0.01% | 4527 |
|
|
2022
Q4 | $65K | Buy |
25,295
+2,120
| +9% | +$5.45K | ﹤0.01% | 4520 |
|
|
2022
Q3 | $48K | Hold |
23,175
| – | – | ﹤0.01% | 4775 |
|
|
2022
Q2 | $32K | Sell |
23,175
-10,729
| -32% | -$14.8K | ﹤0.01% | 4860 |
|
|
2022
Q1 | $76K | Buy |
33,904
+10,329
| +44% | +$23.2K | ﹤0.01% | 4728 |
|
|
2021
Q4 | $105K | Buy |
+23,575
| New | +$105K | ﹤0.01% | 4717 |
|